Hectic year forecast for M&As

Published: 2008-07-16 07:00:00

Updated: 2008-07-16 07:00:00

The mergers and acquisitions market is expected to heat up this year as a number of pharmaceutical firms vows to speed up the takeover bid of promising biopharmaceutical companies.

Major pharmaceutical firms, hungry for growth, are gearing up for the M&As war as the pharmaceutical industry as...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK